These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18400267)

  • 21. Re: Bianco FJ, Scardino PT, and Eastham JA: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("Trifecta") (Urology 66(5 suppl): 83-94, 2005).
    Salomon L
    Urology; 2008 Feb; 71(2):362. PubMed ID: 18308133
    [No Abstract]   [Full Text] [Related]  

  • 22. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
    Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR
    Am J Surg Pathol; 2008 Oct; 32(10):1503-12. PubMed ID: 18708939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy.
    Tsivian M; Sun L; Mouraviev V; Madden JF; Mayes JM; Moul JW; Polascik TJ
    Urology; 2009 Nov; 74(5):1090-3. PubMed ID: 19616835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic radical prostatectomy in clinical T1a and T1b prostate cancer: oncologic and functional outcomes--a matched-pair analysis.
    Teber D; Cresswell J; Ates M; Erdogru T; Hruza M; Gözen AS; Rassweiler J
    Urology; 2009 Mar; 73(3):577-81. PubMed ID: 19100598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of positive surgical margins after radical perineal prostatectomy.
    Goetzl MA; Krebill R; Griebling TL; Thrasher JB
    Can J Urol; 2009 Apr; 16(2):4553-7. PubMed ID: 19364427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].
    Roche JB; Malavaud B; Soulié M; Cournot M; Gamé X; Mazerolles C; Bachaud JM; Plante P; Rischmann P
    Prog Urol; 2008 Oct; 18(9):586-94. PubMed ID: 18986631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative radiation therapy after radical prostatectomy: in regard to Saracino et Al. (Int j radiat oncol biol phys, in press).
    Jereczek-Fossa BA; Orecchia R
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):305-6; author reply 306. PubMed ID: 18722291
    [No Abstract]   [Full Text] [Related]  

  • 29. Robotic-assisted laparoscopic and radical retropubic prostatectomy generate similar positive margin rates in low and intermediate risk patients.
    Laurila TA; Huang W; Jarrard DF
    Urol Oncol; 2009; 27(5):529-33. PubMed ID: 18640061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Fleischmann A; Schlomm T; Köllermann J; Sekulic N; Huland H; Mirlacher M; Sauter G; Simon R; Erbersdobler A
    Prostate; 2009 Jun; 69(9):976-81. PubMed ID: 19274666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transperitoneal laparoscopic prostatectomy does not increase small bowel within the target volume for postoperative radiotherapy.
    Finelli A; Punnen S; Rosewall T; Catton C; Fleshner N; Jewett M; Trachtenberg J; Menard C
    J Urol; 2009 Nov; 182(5):2280-4. PubMed ID: 19762047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of cancer relapse after prostatectomy: use the postoperative nomogram.
    Fromont G
    Clin Cancer Res; 2009 Jan; 15(1):413; author reply 413-4. PubMed ID: 19118074
    [No Abstract]   [Full Text] [Related]  

  • 33. Radical prostatectomy-which patients benefit most from surgery?
    Smith JA
    J Urol; 2006 Aug; 176(2):437. PubMed ID: 16813860
    [No Abstract]   [Full Text] [Related]  

  • 34. Systems pathology and predicting outcome after radical prostatectomy.
    Klein EA; Stephenson AJ; Raghavan D; Dreicer R
    J Clin Oncol; 2008 Aug; 26(24):3916-7. PubMed ID: 18711177
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy.
    Link BA; Nelson R; Josephson DY; Yoshida JS; Crocitto LE; Kawachi MH; Wilson TG
    J Urol; 2008 Sep; 180(3):928-32. PubMed ID: 18635217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy.
    DeCastro GJ; McCann T; Benson MC; McKiernan JM
    Urology; 2008 Dec; 72(6):1214-8. PubMed ID: 18597825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are positive surgical margins in radical prostatectomy specimens an independent prognostic marker?
    Saether T; Sørlien LT; Viset T; Lydersen S; Angelsen A
    Scand J Urol Nephrol; 2008; 42(6):514-21. PubMed ID: 18752153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy for repeat prostate biopsy: predictors of positive biopsy and additional biopsy location.
    Katto K; Takahashi M; Taue R; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Nishitani MA; Kanayama HO
    Urol Int; 2008; 81(2):173-8. PubMed ID: 18758215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy.
    Fujita K; Nakayama M; Nakai Y; Takayama H; Nishimura K; Ujike T; Nishimura K; Aozasa K; Okuyama A; Nonomura N
    Cancer Sci; 2009 Jun; 100(6):1047-50. PubMed ID: 19385972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.